Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Virchows Archiv

• Publication date

  2009-03-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00428-009-0755-5PMID 19294416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.

  2008cited by this paper
• EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number

  2008cited by this paper
• An Aging World – demographics and challenges

  2008cited by this paper
• Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.

  2007cited by this paper
• HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

  2007cited by this paper
• Immunohistochemical study of the expression of HER-2/neu oncogene in ovarian lesions.

  2007cited by this paper
• Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.

  2007cited by this paper
• The impact of epidermal growth factor receptor gene status on gefitinib‐treated Japanese patients with non‐small‐cell lung cancer

  2007cited by this paper
• Association study between epidermal growth factor receptor and epidermal growth factor polymorphisms and endometriosis in a Japanese population

  2007cited by this paper
• Expression of the epidermal growth factor system in endometrioid endometrial cancer.

  2007cited by this paper
• Effect of HER‐2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma

  2007cited by this paper
• Biological Markers for Non–Small Cell Lung Cancer Patient Selection for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

  2006cited by this paper
• Quality of life after laparoscopic colorectal resection for endometriosis.

  2006cited by this paper
• Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis.

  2006cited by this paper
• EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

  2005cited by this paper
• Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta

  2005cited by this paper
• Immunohistochemical investigation and Northern blot analysis of c-erbB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri

  2005cited by this paper
• T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas.

  2005cited by this paper
• Expression of the epidermal growth factor system in human endometrium during the menstrual cycle.

  2005cited by this paper
• Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.

  2004cited by this paper
• HER1/EGFR targeting: refining the strategy.

  2004cited by this paper
• Role of HER receptors family in development and differentiation

  2004cited by this paper
• Biologic and immunologic therapies for ovarian cancer.

  2003cited by this paper
• Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message.

  2001cited by this paper
• c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.

  1998cited by this paper
• Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain.

  1997cited by this paper
• Endometriosis and pelvic pain: relation to disease stage and localization.

  1996cited by this paper
• Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.

  1996cited by this paper
• Endometriosis and pelvic pain: relation to disease stage and localization

  1996cited by this paper
• Immunohistochemical study of c-erb B-2 protein expression in endometriosis.

  1995cited by this paper
• Tissue Factors Influencing Growth and Maintenance of Endometriosis a

  1991cited by this paper
• Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

  1990cited by this paper
• Endometriosis: Pathogenetic Implications of the Anatomic Distribution

  1986cited by this paper

• Human Epidermal Growth Factor Receptor 2 Overexpression/Amplification in Primary Ovarian Endometrioid Carcinoma

  2024cites this paper
• The Association of the Epidermal Growth Factor Receptor (EGFR) Immunoexpression With Prognostic Parameters in Adenocarcinoma Patients Receiving Neoadjuvant Treatment

  2024cites this paper
• Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis

  2021cites this paper
• Uptake and acceptability of genetic counselling amongst breast cancer patients and their families in the uMgungundlovu Municipality in 2004.

  2015cites this paper
• Deep Invasive Endometriosis Lesions of the Rectosigmoid May Be Related to Alterations in Cell Kinetics

  2015cites this paper
• BRCA1, BRCA2, HER2 and RAD51 gene polymorphisms in breast cancer patients of Bangladesh

  2015cites this paper
• Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.

  2014cites this paper
• HER 1 R 497 K and HER 2 I 655 V polymorphisms are linked to development of breast cancer

  2014cites this paper
• HER1 R497K and HER2 I655V Polymorphisms Are Linked to Development of Breast Cancer

  2013cites this paper
• HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies

  2013cites this paper
• ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling

  2013cites this paper
• Paired-box gene 2 is down-regulated in endometriosis and correlates with low epidermal growth factor receptor expression.

  2012cites this paper
• Endometriosis and ovarian cancer

  2010cites this paper
• Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

  2009cites this paper